Pfizer (PFE)
(Delayed Data from NYSE)
$23.90 USD
-0.07 (-0.29%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $23.93 +0.03 (0.13%) 5:58 PM ET
3-Hold of 5 3
A Value F Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Pfizer Inc. has a market cap of $136.28B, which represents its share price of $23.97 multiplied by its outstanding shares number of 5.69B. As a large-cap company, PFE's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PFE 23.90 -0.07(-0.29%)
Will PFE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PFE
MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer
Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
CorMedix Rallies 60% YTD: Is This an Indication to Buy the Stock?
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
Other News for PFE
Oncology Investment Surge Hits $1.3B as Private Sector Fills Public Funding Gaps
Oncology Investment Surge Hits $1.3B as Private Sector Fills Public Funding Gaps
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Mixed options sentiment in Pfizer with shares up 0.27%
Mixed options sentiment in Pfizer with shares up 0.27%